Description
Guidance documents for management of drugs for clinical trials involving human subjects. The sponsor must ensure that the clinical trial is conducted in accordance with the requirements of the protocol, which has been authorized by Health Canada and approved by REB(s).
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors | HTML | Open resource | |
| Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors | HTML | Open resource |